---
title: "If Europe Pulls Back: Who Fills the Gap When Gavi and the Global Fund Lose EU Support?"
description: EU funding shifts threaten Gavi and the Global Fund – putting vaccines at risk in Uganda, widening HIV treatment gaps and undermining routine immunisation.
author: Dr Marina Nani (Editor-in-Chief)
date: 2025-10-30T14:55:00.000Z
updated: 2026-02-26T18:01:44.149Z
canonical: https://www.sovereignmagazine.com/article/if-europe-pulls-back-who-fills-the-gap-when-gavi-and-the-global-fund-lose-eu-support
image: https://cdn.nanimediahouse.com/ea5eac21-c44c-4e37-9a45-1a6cb3f3b0de.jpg
categories: Social Impact
content_type: Analysis
region: Kenya
publication: Sovereign Magazine
---

The morning vaccination clinic at Kamuli District Hospital in eastern Uganda runs on predictable rhythms. Every Wednesday, mothers queue with their infants for routine immunisations – measles, polio, DTP3. The vaccines arrive monthly via Gavi-supported cold chain trucks, maintaining the crucial 2-8 degree temperature range across the 120-kilometre journey from the regional depot. Last month, when the generator failed during a power cut, the backup solar freezer system kept doses viable. Without it, clinic nurse Sarah Namugera estimates they would have lost three weeks of vaccine stock worth $4,000.

‘We had a close call in September when the cold truck broke down halfway,’ Namugera said in an interview from the clinic. ‘The driver managed to transfer everything to a backup vehicle within two hours. If we’d lost that shipment, 800 children would have missed their scheduled doses.’

This [frontline reality of vaccine delivery](https://www.sovereignmagazine.com/article/australia-steps-into-a-funding-vacuum-in-the-pacific-but-smaller-chinese-grants-may-be-winnin) may face upheaval if the European Union follows through on suggestions in an internal briefing to end funding for organisations like Gavi, the Vaccine Alliance, and the Global Fund by 2030. According to [an exclusive report by Euractiv](https://www.euractiv.com/news/exclusive-eu-mulls-copying-us-with-end-to-aid-for-global-health-funds/), the European Commission document prepared for Commissioner for International Partnerships Jozef Síkela states that the bloc should ‘focus on funds where the EU can truly shape governance.’

The briefing reveals stark numbers about current EU contributions: since 2021, the bloc has provided €3.5 billion to global funds, including €1.5 billion annually through UN agencies and €1.5 billion to 152 World Bank trust funds. For Gavi specifically, the [European Commission pledged €360 million](https://civil-protection-humanitarian-aid.ec.europa.eu/news-stories/news/european-commission-pledges-eu260-million-gavi-2026-2027-and-over-eu200-million-additional-2024-09-29_en) at the organisation’s 2026-2030 replenishment event, which raised approximately $9.5 billion (€8.1 billion) but fell short of its $11.9 billion (€10.2 billion) target. This shift in [EU funding priorities](https://www.sovereignmagazine.com/article/eu-deepens-financial-backing-of-middle-east-peace-efforts-as-international-funding-rises) reflects broader strategic recalibrations in Brussels.

## How the Funds Work and What ‘Sunset Clauses’ Mean

Gavi negotiates bulk vaccine purchases for 57 lower-income countries, reducing prices through volume guarantees while funding cold chain infrastructure and health worker training. The Global Fund channels resources to country-led programmes fighting AIDS, tuberculosis and malaria. Both organisations claim significant impact – Gavi reports 20.6 million lives saved since 2000, while the Global Fund cites 70 million lives saved through prevention and treatment interventions.

The EU briefing’s suggestion of ‘sunset clauses’ would set definitive end dates for funding commitments. Unlike gradual transitions based on country income levels, sunset provisions create hard deadlines regardless of local capacity. The document notes that Gavi ‘has no clear exit plan,’ acknowledging that most beneficiary countries will require support beyond 2030.

## Policy Timeline and EU Politics

This funding reconsideration aligns with the EU’s Multiannual Financial Framework negotiations for 2028-2034. Commission President Ursula von der Leyen has outlined alternative health financing approaches, including a [Global Health Resilience Initiative](https://www.euronews.com/health/2025/09/10/eu-health-agenda-goes-global-in-von-der-leyens-address) announced in her 2025 State of the Union address. In October, she launched the [Global Gateway Investment Hub](https://news.fundsforngos.org/2025/10/13/president-von-der-leyen-global-gateway-reaches-e300-billion-expands-smart-and-clean-global-links/), positioning it as an ‘agile’ platform for public and private actors. The Global Gateway programme has already mobilised over €300 billion, exceeding initial targets, as part of [Von der Leyen’s broader strategic initiatives](https://www.sovereignmagazine.com/article/resourceeu-can-brussels-turn-von-der-leyen-s-plan-into-the-industrial-muscle-europe-s-carmake).

## Country-Level Consequences

In Uganda, where 91% of children receive DTP3 vaccines according to WHO-UNICEF estimates, Gavi support underpins the entire immunisation system. The country receives approximately $40 million annually in vaccine procurement and cold chain maintenance through the alliance. Health ministry data shows districts with functional cold chains maintain 85-90% coverage rates, while those without drop to 60-65%.

Zimbabwe’s HIV treatment programme illustrates Global Fund dependence at scale. The fund provides 67% of antiretroviral therapy financing, covering 1.2 million people living with HIV. Programme evaluations indicate that a 30% funding reduction would force treatment rationing, potentially affecting 360,000 patients. The country’s health ministry projects it could absorb at most 15% of current Global Fund expenses by 2030.

In Chad, measles vaccination coverage hovers at 41% according to 2024 WHO-UNICEF data. Gavi finances both vaccine procurement and the logistics network reaching nomadic populations. The country’s health budget equals $7 per capita annually – below the cost of a single measles-rubella dose including delivery.

## Financial Substitutions and Risk Transfer

The EU briefing suggests moving from predictable grants towards public-private partnerships and conditional funding tied to governance reforms. This approach fundamentally reallocates risk from donors to recipient countries and private investors. Under current models, Gavi guarantees vaccine purchases years in advance, allowing manufacturers to maintain production lines. Private investment models typically require returns, favouring urban clinics over rural immunisation outreach.

Previous experiments with private health financing in sub-Saharan Africa demonstrate the limitations. A 2023 evaluation of healthcare public-private partnerships in Kenya found that private operators withdrew from 40% of rural facilities within three years due to low profitability. Routine immunisation programmes, which generate no direct revenue, proved particularly unattractive to investors seeking 12-15% returns.

## Health Outcomes Under Funding Scenarios

Academic modelling suggests significant health impacts from EU funding withdrawal. A moderate scenario with 30% reduction in predictable funding could decrease routine immunisation coverage by 8-12 percentage points across Gavi-eligible countries by 2030. This translates to approximately 4.8 million additional unvaccinated children annually. For measles alone, epidemiological models project this coverage drop would trigger outbreaks affecting 200,000-300,000 children yearly.

Under a severe scenario with complete EU withdrawal by 2030, combined with similar moves by other donors, models indicate potential collapse of immunisation programmes in 12-15 countries. Emergency vaccine stockpiles would deplete within 18 months, leaving countries unable to respond to outbreaks. HIV treatment interruptions could affect 2.4 million people across sub-Saharan Africa, with drug resistance emerging within 6-12 months of treatment gaps. These [health funding challenges](https://www.sovereignmagazine.com/article/aca-funding-fight-puts-employee-health-benefits-at-risk-as-government-shutdown-looms) reflect broader tensions in global healthcare financing.

## US and UK Context

The EU’s reconsideration follows similar donor fatigue elsewhere. The UK [cut Gavi funding by £400 million](https://www.independent.co.uk/news/health/uk-aid-cuts-budget-vaccine-gavi-b2776890.html) for 2026-2030, reducing its pledge from £1.65 billion to £1.25 billion – a 25% decrease. This reduction comes amid broader [UK spending pressures](https://www.sovereignmagazine.com/article/labour-s-2-7-trillion-spending-review-tight-margins-and-investors-on-alert) and fiscal constraints. The United States, traditionally the largest global health donor, signalled potential reductions to both Gavi and Global Fund contributions in 2025 budget proposals, though final appropriations remain pending Congressional approval.

## Looking Ahead

Back at Kamuli District Hospital, nurse Namugera calculates what a Gavi exit would mean practically. The government covers her salary and basic supplies, but vaccines, cold chain maintenance and outreach fuel come entirely through Gavi channels. ‘Without that support, we’d return to the situation of the 1990s – mothers walking 30 kilometres hoping to find vaccines in stock, often going home with nothing.’

The EU’s funding trajectory will become clearer during MFF negotiations in early 2026, with the Global Fund replenishment conference on 21 November offering an immediate test of donor commitment. The next critical juncture arrives with the Commission’s 2026 budget proposal, expected in May, which will signal whether ‘sunset clauses’ move from briefing papers to policy reality.